Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults

Completed

• Conditions: Frailty; Frailty Syndrome; Frail Elderly Syndrome; Pre-Frailty; Healthy; Healthy Aging; Aging Problems; Aging Disorder

• Registration Number: NCT05961319
• Lead Sponsor: University of Alberta

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-6-26
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

Inclusion Criteria:<br><br> - In-patients at the Glenrose Rehabilitation Hospital (GRH) and GRH' visitors or staff<br> (e.g. patients' caregivers, relatives, friends of older adults in-patient or staff<br> at the GRH who are interested in participating) who are 65 years old or older<br><br> - For in-patients who are pre-frail or frail according to the scale used at the GRH<br> (can be equivalent to Fried's scale pre-frail/frail (score = 1 - 4). For GRH's<br> visitors or staff, are robust according to Fried's Frail Scale (score=0) as per the<br> definition in (Fried, 2001)<br><br> - With or without some level of cognitive impairment (Standardized mini-mental state<br> examination (MMSE) of 21 to 30 (mild (24-21) to could be normal (25-30)) or the<br> equivalent in the screening tool.<br><br> - Have a cognitive ability to interact with the frailty sensors (i.e. scale,<br> dynamometer, smart speaker).<br><br> - Have a functional vision and hearing with or without aides (glasses/hearing aids) to<br> be able to interact with furniture and sensors at the ILS and to fill out<br> questionnaires.<br><br> - Have functional upper extremity function to be able to interact with furniture and<br> sensors at the ILS.<br><br> - Be able to walk independently 15 meters with or without a walking aid.<br><br> - If taking antidepressants or narcotics, participants have no changes in the<br> medication for at least 3 months<br><br>Exclusion Criteria:<br><br> - Those with a history of Parkinson's disease or other movement disorders or stroke.<br><br>Justification: Movement disorders causing tremors will affect data collection by the<br>sensors<br><br> - Those who were taking Sinemet or Aricept<br><br> - Older adults who have Influenza, long Covid-19 or another virus that affect their<br> performance<br><br> - Unable to count, speak (name objects and say numbers) or comprehend simple<br> instructions in English<br><br> - Have severe cardiac or respiratory diseases that prevent them to perform vigorous<br> activities<br><br> - Using supplemental oxygen (i.e., must be able to breathe with room air)

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Slowness (Mobility);Weight (lbs, Kgs);Exhaustion;Strength - Handgrip;Activity;Meal Preparation;Observe Free Activity;Qualitative Interviews Regarding Technology